Document is current
Any future updates will be listed below
-
Authors
Arutiunian, Vardan
Santhosh, Megha
Neuhaus, Emily
Borland, Heather
Bernier, Raphael A.
Bookheimer, Susan Y.
Dapretto, Mirella
Gupta, Abha R.
Jack, Allison
Jeste, Shafali
McPartland, James C.
Naples, Adam
Van Horn, John D.
Pelphrey, Kevin A.
Webb, Sara Jane
-
Funding
Funding for this research was provided by:
Autism Research Institute
- License Information
-
More Information
Article History
Received: 30 December 2025
Accepted: 20 June 2026
First Online: 26 June 2026
Declarations
:
: James C. McPartland consults or has consulted with Customer Value Partners, Bridgebio, Determined Health, Apple, Neumarker, and BlackThorn Therapeutics, has received research funding from Janssen Research and Development, serves on the Scientific Advisory Boards of Pastorus and Modern Clinics, and receives royalties from Guilford Press, Lambert, Oxford, and Springer. The remaining authors have no conflict of interest to declare.
: The study was approved by the Yale Institutional Review Board, the UCLA Office of Human Research Protection Program, Boston Children’s Hospital Institutional Review Board, USC Office for the Protection of Research Subjects, and the University of Virginia Institutional Review Board for Health Sciences Research. All procedures performed were in accordance with the Declaration of Helsinki. All minor children provided verbal assent to participate in the study and were informed that they can withdraw from the study at any time during the experiment. A written informed consent form was obtained from a parent of each child participating in the study.
